Health Care M&Deals, Week Ending February 22, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Merck & Co., Inc. Immune Design $300,000,000 Janssen Biotech, Inc. Collaboration on novel integrin therapeutics N/A ICON plc MolecularMD N/A eHealth Acquirer Target Price Harris Computer Systems Collain Healthcare, LLC N/A symplr API Healthcare N/A... Read More »
Health Care M&Deals, Week Ending February 15, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price AbbVie, Inc. Commercialization and development rights for TNB-383B $90,000,000 Labs, MRI & Dialysis Acquirer Target Price RadNet, Inc. Kern Radiology Medical Group, Inc. N/A Private investor group U.S. Renal Care, Inc. N/A Long-Term Care Acquirer... Read More »
Health Care M&A Deals, Week Ending February 8, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price GlaxoSmithKline plc Collaboration on M7824 $342.3 million Cullinan Pearl License to TAS6417 N/A Galapagos NV Collaboration on fibrotic disease therapies N/A Genentech, Inc. Global rights to IL-15 cytokine therapeutics $120,000,000 eHealth... Read More »
Healthcare Deal Volume Got a Jump Start in January
January was a fairly busy month for healthcare M&A. Preliminary data shows 133 deals reported, nearly equal to December’s 136. The momentum coming out of the fourth quarter spilled into the new year and even without a big boost in deal announcements from the J.P. Morgan Healthcare Conference, consolidation in the industry seems to be going full steam ahead. And yet. Compared with the 151 deals announced a year ago, M&A is off by 12%. Granted, we don’t see that many deals on a monthly basis, which makes for a hard comp here. But as we swing into February, deal flow has slowed noticably. It could be temporary, as investors take stock of the economic and political landscape and... Read More »
Health Care M&A Deals, Week Ending February 1, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Aldeyra Therapeutics, Inc. Helio Vision, Inc. $10,000,000 Neurocrine Biosciences, Inc. Rights to four gene therapy programs $165,000,000 Janssen Pharmaceuticals, Inc. Rights to retinal disease treatments $100,000,000 Tetra Bio-Pharma Panag... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
